330 related articles for article (PubMed ID: 18078659)
1. [Treatment of patients with type 2 diabetes mellitus with pioglitazone. A survey of a Cochrane review].
Madsbad S
Ugeskr Laeger; 2007 Nov; 169(47):4054-7. PubMed ID: 18078659
[No Abstract] [Full Text] [Related]
2. [The benefit of pioglitazone in patients with diabetes mellitus type 2 and cardiovascular complications].
Olsovský J
Vnitr Lek; 2005 Dec; 51(12):1412. PubMed ID: 16430111
[No Abstract] [Full Text] [Related]
3. [Glitazones in type 2 diabetes--documented risks, uncertain benefits].
Håkansson J
Lakartidningen; 2007 Oct 24-30; 104(43):3198-200. PubMed ID: 18018937
[No Abstract] [Full Text] [Related]
4. Pioglitazone/glimepiride (Duetact) for diabetes.
Med Lett Drugs Ther; 2007 Jan; 49(1253):9-11. PubMed ID: 17261966
[No Abstract] [Full Text] [Related]
5. Pioglitazone + glimepiride: a combination product to avoid.
Prescrire Int; 2007 Aug; 16(90):145. PubMed ID: 17724836
[No Abstract] [Full Text] [Related]
6. Pioglitazone-induced progressive pancytopenia.
Favre G; Valnet-Rabier MB; Brousse A; Lepiller Q; Kantelip JP
Ann Pharmacother; 2011 Jan; 45(1):131-3. PubMed ID: 21205948
[No Abstract] [Full Text] [Related]
7. Pioglitazone/metformin (Actoplus met).
Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
[No Abstract] [Full Text] [Related]
8. Glitazones in type 2 diabetes: an update.
Drug Ther Bull; 2008 Apr; 46(4):25-9. PubMed ID: 18403615
[TBL] [Abstract][Full Text] [Related]
9. The value equation for rosiglitazone and pioglitazone in older persons.
Zarowitz BJ
Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172
[No Abstract] [Full Text] [Related]
10. [The true place of glitazones in the treatment of diabetes: after the PROactive study].
Lindberg M; Jørgensen PH; Kampmann JP
Ugeskr Laeger; 2006 Jun; 168(25):2477-9; author reply 2479-80. PubMed ID: 16824389
[No Abstract] [Full Text] [Related]
11. Thiazolidinediones.
Mascitelli L; Pezzetta F
N Engl J Med; 2005 Jan; 352(2):205-7; author reply 205-7. PubMed ID: 15651125
[No Abstract] [Full Text] [Related]
12. Dyslipidaemia in type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone.
Mukhtar R; Reckless JP
Diabet Med; 2005 Jul; 22 Suppl 3():6-10. PubMed ID: 15960775
[No Abstract] [Full Text] [Related]
13. [Pioglitazone].
Aso Y
Nihon Rinsho; 2012 May; 70 Suppl 3():620-6. PubMed ID: 22768588
[No Abstract] [Full Text] [Related]
14. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.
Lehmann DF; Lohray BB
J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500
[No Abstract] [Full Text] [Related]
15. [Glitazones--again].
Halse J
Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2707; author reply 2707. PubMed ID: 17952161
[No Abstract] [Full Text] [Related]
16. [Pioglitazone in evaluation by IQWiG (Institute for Quality and Cost Effectiveness in Public Health)--tunnel vision instead of broad view].
MMW Fortschr Med; 2008 Aug; 150(32-35):56-7. PubMed ID: 19009700
[No Abstract] [Full Text] [Related]
17. Thiazolidinediones and congestive heart failure: a judicious balance of risks and benefits.
Patel RR
Cardiol Rev; 2009; 17(3):132-5. PubMed ID: 19384087
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.
Krentz A
Diabetes Metab Res Rev; 2009 Feb; 25(2):112-26. PubMed ID: 19219860
[TBL] [Abstract][Full Text] [Related]
19. Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
Consoli A; Formoso G
Diabetes Obes Metab; 2013 Nov; 15(11):967-77. PubMed ID: 23522285
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
Khanderia U; Pop-Busui R; Eagle KA
Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
